Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells

PLoS ONE(2022)10.1371/journal.pone.0271674Source: DataRank Database

HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.72)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Valeri H. Terry ORCID,Mary K. Lewinski ORCID,Savitha Deshmukh ORCID,Nadejda Beliakova‐Bethell ORCID,Celsa A. Spina ORCID

Live enrichment

PubMed:35895672 PMC:PMC9328514 OpenAlex:https://openalex.org/W4288052082

U.S. Department of Veterans Affairs

Grant: I01 BX001160

U.S. Department of Veterans Affairs

Grant: IK2 BX002731

National Institutes of Health

Grant: AI080193

National Institutes of Health

Grant: AI096113

National Institutes of Health

Grant: AI036214

National Institutes of Health

Grant: M01 RR000827

National Institutes of Health

Grant: AI157755

NCATS NIH HHS

Grant: UL1 TR001442

NIAID NIH HHS

Grant: R56 AI157755

NIAID NIH HHS

Grant: U19 AI096113

NIAID NIH HHS

Grant: P01 AI080193

NIAID NIH HHS

Grant: P30 AI036214

California HIV/AIDS Research Program

FWCI

0.72

Citation Percentile

0.7%

Citation Trend

2016

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0271674&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0271674&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0271674

journalhttps://doi.org/10.1371/journal.pone.0271674

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35895672

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionT-cell and B-cell ImmunologyCD4-Positive T-LymphocytesHIV InfectionsHIV SeropositivityHIV-1HumansVirus LatencyVirus Replication

MeSH Terms

HIV SeropositivityHumansVirus ReplicationCD4-Positive T-LymphocytesHIV-1HIV InfectionsVirus Latency

Keywords

ProvirusBiologyCell growthCell divisionStimulationCell biologyCell cultureVirus latencyViral replicationCell sortingCellFlow cytometryVirologyT cellVirusImmunologyImmune systemGeneticsGeneNeuroscience

Sustainable Development Goals

SDG 0: Good health and well-being

HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells

FAIR Checklist

Authors (6)

Funding (13 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)